Johnson & Johnson: Why I See Downside Ahead
Source: SeekingAlpha
2026-04-17 10:42:35 ET
So, since my last article , " Johnson & Johnson: Strong Run May Be Ending, " which, by the way, caused an extremely negative reaction from you, Johnson & Johnson ( JNJ ) aka J&J stock has fallen 4.2%, underperforming the S&P 500 [1.8% return] ( SPY )....
Read the full article on Seeking Alpha
For further details see:
Johnson & Johnson: Why I See Downside Ahead
AbbVie Inc.
NASDAQ: ABBV
ABBV Trading
2.61% G/L:
$229.18 Last:
2,858,492 Volume:
$227.37 Open:
ABBV Latest News
June 02, 2026 02:50:00 pm
Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic
June 02, 2026 10:05:00 am
The S&P 500 Is Expensive, but These 3 Dividend Stocks Still Look Like Bargains
June 02, 2026 08:00:00 am
AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
ABBV Stock Data
$396,361,630,803
1,749,710,786
N/A
2503
N/A
Pharmaceuticals
Healthcare
US
North Chicago
